1,799 results on '"Drug therapy, Combination"'
Search Results
2. Rethinking cancer drug synergy prediction: a call for standardization in machine learning applications
3. Combined inhibition of MDM2 and PARP lead to a synergistic anti-tumoral response in p53 wild-type rhabdomyosarcoma models
4. Merck to discontinue phase 3 KeyVibe-003 & KeyVibe-007 trials of vibostolimab and favezelimab FDCs with pembrolizumab in certain patients with NSCLC
5. How to Predict Effective Drug Combinations - Moving beyond Synergy Scores
6. Researchers at University of Melbourne Release New Data on Antifungals (Reassessment of the Role of Combination Antifungal Therapy In the Current Era)
7. NPPA revises draft working sheet for Glenmark's cardiovascular drug following review order
8. DSA-DeepFM: A Dual-Stage Attention-Enhanced DeepFM Model for Predicting Anticancer Synergistic Drug Combinations
9. New Findings from Uppsala University in the Area of Antimicrobial Chemotherapy Published [Therapeutic drug monitoring (TDM) of b-lactam/b-lactamase inhibitor (BL/BLI) drug combinations: insights from a pharmacometric simulation study]
10. Data on Dyslipidemias Discussed by Researchers at I.M. Sechenov First Moscow State Medical University (Optimal treatment strategies in comorbid patients with hypertension and dyslipidemia: the role of fixed-dose combinations)
11. SynDRep: A Knowledge Graph-Enhanced Tool based on Synergistic Partner Prediction for Drug Repurposing (Updated October 11, 2024)
12. Development of Mini-Tablet and Multi-Unit Pellet Systems: Advanced oral dosage forms allow for modulation of controlled- and sustained-release profiles
13. Determining sex differences in drug combinations targeting aortic valve myofibroblast activation using an artificial intelligence derived platform
14. Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More
15. Novavax reports FDA placed clinical hold on IND for COVID-flu combo vaccine
16. Research Results from Seth GSMC and KEM Hospital Update Knowledge of Paracetamol Therapy (A pharmacokinetic profiling study after single-tablet regimen of camylofin 50 mg and paracetamol 325 mg in healthy participants)
17. A Right Step Towards Tb Eradication
18. Researchers Submit Patent Application, 'Drug Combination Of Fak Inhibitor And Immunogenic Cell Death Inducer And Use Thereof', for Approval (USPTO 20240285627)
19. Prediction and principle discovery of drug combination based on multimodal friendship features
20. SynDRep: A Knowledge Graph-Enhanced Tool based on Synergistic Partner Prediction for Drug Repurposing
21. Centre approves introduction of BPaLM treatment regimen for drug-resistant T
22. Drug combination prediction for cancer treatment using disease-specific drug response profiles and single-cell transcriptional signatures (Updated August 14, 2024)
23. MDC recommends retail prices for anti-diabetes combinations of empagliflozin
24. New Antiarrhythmic Agents Findings Reported from University of Belgrade [Oxorhenium(V) Complexes With Pyridinedicarboxylic Ligands: Synthesis, Density Functional Theory Calculations, and Drug Combination Study]
25. Merck to discontinue phase 3 KeyVibe-008 trial of fixed-dose combination of vibostolimab and pembrolizumab in patients with extensive-stage SCLC
26. Merck to discontinue Phase 3 KeyVibe-008 trial based on recommendation of DMC
27. BRIO-1 study results show renewed hope for medical presbyopia correction
28. Research Reports from Croatian Institute of Transfusion Medicine Provide New Insights into Pseudomonas aeruginosa (In Vitro Antibiofilm Activity of Fosfomycin Alone and in Combination with Other Antibiotics against Multidrug-Resistant and ...)
29. Drug combinations with apoptosis pathway targeted agents alrizomadlin, pelcitoclax, and dasminapant in multi-cell type tumor spheroids
30. Studies from Indian Institute of Technology Roorkee Update Current Data on Breast Cancer (Folate Functionalized Multifunctional Cuo@phbv@pda Nanoplatform for Ph-responsive Dual Drug Delivery and Ros-driven Apoptosis In Breast Cancer)
31. Study Findings from Janssen Pharmaceutical Companies of Johnson & Johnson Provide New Insights into Endothelin Receptor Antagonists (Bioequivalence and the Food Effect of Macitentan/tadalafil 10/20 Fixed-dose Combination Tablets Versus the Use ...)
32. Researchers at Sirjan University of Technology Release New Data on Anticancer Agents (The Role of Hydrogen Bonds On the Stability of Anticancer Drug Compounds Tg/uracil, Tg/5-fluorouracil and Tg/gimeracil)
33. NPPA rejects Abbott's application for special retail price for flagyl gel with soft adapter tip applicator
34. Moderna Announces Good Results From Trial of Combo COVID/Flu Vaccine
35. FDA Approves First Generics of Heart Failure Combo Drug Entresto
36. Researchers at Children's Hospital Philadelphia Have Reported New Data on Gliomas (Spheroid Drug Sensitivity Screening In Glioma Stem Cell Lines)
37. Study Results from Birla Institute of Technology and Science in the Area of Glioblastomas Reported (The Power of Synergism: a Novel Drug Combination for Improved Therapy of Glioblastoma)
38. Orchid Pharma gets DCGI approval to manufacture & market antibiotic drug combination of cefepime and enmetazobactam
39. MDC rejects Abbott's application for special retail price for mouth ulcer combination drug
40. NPPA revises ceiling price of asthma inhaler drug combination in suo-moto correction
41. Otsuka Ends Development of Combo Drug for Agitation in Alzheimer Disease
42. Second Phase 3 trial shows benefit of xanomeline-trospium in schizophrenia
43. India puts in place mechanisms to combat malaria as drug resistance poses serious challenge
44. Dual-view jointly learning improves personalized drug synergy prediction
45. Patent Issued for All-in-one fixed-dose combination for treating Helicobacter pylori infection (USPTO 11931463)
46. New Data from North-West University Illuminate Findings in Pharmaceutics (Fixed-dose Combination Formulations In Solid Oral Drug <break/>therapy: Advantages, Limitations, and Design Features)
47. Deciphering molecular mechanisms of synergistic growth reduction in kinase inhibitor combinations
48. Acceptability of fixed-dose combination treatments for hypertension in Kenya: a qualitative study using the Theoretical Framework of Acceptability
49. DCGI directs SLAs to cancel product permission to antibiotic combo of meropenem & disodium EDTA for injection
50. DCGI directs SLAs to cancel product permission to antibiotic combo of meropenem & disodium EDTA for injection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.